References
  1. Feldman T, Foster E, Glower DD, et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 2011;364:1395-406.
  2. Stone GW, Lindenfeld J, Abraham WT, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med. 2018;379:2307-18.
  3. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease. Circulation 2021;143:e72–227.
  4. Baumgartner, H, Falk V, Bax JJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J 2017;38:2739–2791.
  5. Blasé A Carabello. The current therapy for mitral regurgitation. J Am Coll Cardiol. 2008;52:319-26.
  6. Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation. 2001;103:1759-64.
  7. Grossi EA, Crooke GA, DiGiorgi PL, et al. Impact of moderate functional mitral insufficiency in patients undergoing surgical revascularization. Circulation. 2006;114:I573-6.
  8. MackJM, Lindenfeld J, Abraham WT, et al. 3-year outcomes of transcatheter mitral valve repair in patients with heart failure. J Am Coll Cardiol. 2021;77:1029-1040.
  9. Mauri L, Foster E, Glower DD, et al. 4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation. J Am Coll Cardiol. 2013;62:317-28.
  10. Kitamura H, Kagase A, Koyama Y, et al. Early and long-term results of surgery for secondary mitral regurgitation with a damaged heart. J Cardiac Surg. 2019;34:919-926.
  11. Acker MA, Parides MK, Perrault LP, et al. Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med. 2014;370:23-32.
  12. Goldstein D, Moskowitz AJ, Gelijns AC, et al. Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med. 2016;374:344-53.
  13. Calafiore AM, Di Mauro M, Gallina S, et al. Mitral valve surgery for chronic ischemic mitral regurgitation. Ann Thorac Surg. 2004;77:1989-97.
  14. Komeda M, Koyama Y, Fukaya S, Kitamura H. Papillary heads “optimization” in repairing functional mitral regurgitation. J Thorac Cradiovasc Surg. 2012;144:1262-4.
  15. Bauersachs J. Heart failure drug treatment: the fantastic four. Eur Heart J 2021;42:681-683.
  16. Ellis SG, Whitlow PL, Raymond RE, Schneider JP. Impact of mitral regurgitation on long-term survival after percutaneous coronary intervention. Am J Cardiol. 2002;89:315-8.
  17. Goel SS, Bajaj N, Aggarwal B, et al. Prevalence and outcomes of unoperated patients with severe symptomatic mitral regurgitation and heart failure: comprehensive analysis to determine the potential role of MitraClip for this unmet need. J Am Coll Cardiol. 2014;63:185-6.
  18. Gregorevic KJ, Hubbard RE, Lim WK, Katz B. The Clinical Frailty Scale predicts functional decline and mortality when used by junior medical staff: a prospective cohort study. BMC Geriatr. 2016;16:117.
  19. Reichart D, Rosato S, Nammas W, et al. Clinical Frailty Scale and outcome after coronary aretery bypass grafting. Eur J Cardiothorac Surg. 2018;54:1102-1109.
  20. Shimura T, Yamamoto M, Kano S, et al. Impact of the Clinical Frailty Scale on outcomes after transcatheter aortic valve replacement. Circulation. 2017;35:2013-2024.